Prot#R3918-MG-2018: Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Generalized Myasthenia Gravis

Project: Research project

Project Details

StatusActive
Effective start/end date3/30/223/30/25

Funding

  • PPD Investigator Services, LLC (Prot#R3918-MG-2018)
  • Regeneron Pharmaceuticals, Inc. (Prot#R3918-MG-2018)